Allevi, Inc.

Acquired

Developer of 3D bioprinters and bioinks intended to cure disease, eliminate the organ waiting list and reverse climate change. The company's 3D bioprinters and bioinks provide a printer that uses a special ink combined with biomaterials and living cells to build 3D living tissue and miniature human organs to unleash the biological revolution

What it does

Allevi 3D bioprinters and bioinks are trusted by bioprinting researchers globally for tissue engineering, organ on a chip, pharmaceuticals, and more.

Next to it in Healthcare and bio · 3D bioprinting for organ manufacturing

  • Asuka MedicalPlug and Play

    Asuka Medical is a professional manufacturer of medical laser equipment.

  • 株式会社サイフューズPlug and Play

    Cyfuse Biomedical develops tissue fabrication systems and cell-based products in Japan and internationally.

  • Prellis BiologicsPlug and Play

    Prellis Biologics is building human tissues for drug development, and ultimately, developing human organs for transplantation.

  • ティシューバイネット株式会社Plug and Play

    Tissue by Net is a contract manufacturer producing cell blocks from client-provided cells and media, with fibroblasts and MSCs as standards.

  • Sipeng TechnologyPlug and Play

    Sipeng Technology is a new form of synthetic biology high-tech company.

  • AnivancePlug and Play

    Drug development solution, Paitent on chips

  • 株式会社セルファイバPlug and Play

    Cell fiber technology was developed as a basic technology for handling cells in the engineering field.

  • EnzymasterPlug and Play

    Enzymaster focuses on the development and commercialization of enzymes for the innovative and sustainable production of API intermediates.